Revenue
2023
2024
2025
Cellyan Biotechnology Co., Ltd (HKPD)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $20.3M | $16.7M | $12.6M |
| Gross profit | $2.4M | $3.6M | $2.7M |
| Operating income | −$2.3M | −$2.0M | −$1.8M |
| EBITDAderived | −$2.2M | −$1.9M | −$1.7M |
| Net income | −$27,056 | $1.3M | $998,196 |
| Basic EPSper diluted share | -$0.00 | $0.18 | $0.15 |
| Diluted EPSper diluted share | -$0.00 | $0.18 | $0.15 |